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The Relationship Between IQ,Memory, Executive Function, and Processing Speed in
Recent-Onset Psychosis: 1-Year Stability and Clinical Outcome
Verity C. Leeson1–3, Thomas R. E. Barnes2,
Masuma Harrison2, Elizabeth Matheson2,3,
Isobel Harrison2, Stanley H. Mutsatsa2, Maria A. Ron3,
and Eileen M. Joyce2,3
2Imperial College Faculty of Medicine, London, UK; 3Institute of
Neurology, University College London, UK
Studies commonly report poor performance in psychotic
patients compared with controls on tasks testing a range
of cognitive functions, but, because current IQ is often
not matched between these groups, it is difficult to deter-
mine whether this represents a generalized deficit or specific
abnormalities. Fifty-three first-episode psychosis patients
and 53 healthy controls, one-to-one matched for sex,
age, and full-scale current IQ, were compared on Wechsler
Adult Intelligence Scale (WAIS) subtests representing in-
dices of perceptual organization, verbal comprehension,
processing speed, and working memory as well as other
tests of executive function and episodic memory. The
groups showed an equivalent pattern of performance on
all WAIS subtests except digit symbol processing speed,
on which the patients were significantly worse. Patients
were also worse on measures where performance correlated
with digit symbol score, namely working and verbal mem-
ory tasks. Standardized residual scores for each subtest
were calculated for each patient using the difference be-
tween their actual subtest score and a predicted subtest
score based on their full-scale IQ and the performance
of controls. Scaled scores and residual scores were exam-
ined for relationships with clinical measures. Digit symbol–
scaled score was significantly correlated with concurrent
negative syndrome score at baseline, and digit symbol re-
sidual score significantly predicted residual negative symp-
toms at 1-year follow-up. In summary, our comparison of
patients and controls precisely matched for IQ revealed
that processing speed was attenuated in recent-onset
schizophrenia, contributed significantly to working and ep-
isodic memory deficits, and was a prognostic factor for
poor outcome at 1 year.
Key words: schizophrenia/cognition/intelligence
Introduction
A wide range of cognitive deficits are present at the onset
of psychosis in people with schizophrenia.1,2 Large-scale
studies comparing schizophrenia patients, recruited in an
unbiased way as they present with their first psychotic
episode, with healthy controls, recruited from the same
community, find decrements in memory and executive
function as well as Wechsler Adult Intelligence Scale
(WAIS) IQ.3–6 When general intellectual ability is con-
trolled by matching for WAIS IQ, impairments in mem-
ory and executive function can still be discerned in
patients with first-episode and more long-term schizo-
phrenia.7–11 Such findings suggest that impairments in
these cognitive domains are central to schizophrenia.
Matching for WAIS IQ does not ensure equivalence on
the cognitive components contributing to general ability.
For example, schizophrenia patients tend to have higher
verbal IQ relative to performance IQ when compared
with IQ-matched controls.1,10–12 Wilk et al13 investigated
this in more detail by comparing the performance of
Wechsler Adult Intelligence Scale III (WAIS-III) IQ–
matched schizophrenia patients and healthy controls on
the indices of working memory, processing speed, percep-
tual organization, and verbal comprehension. They found
that control performance was equivalent across all 4 indi-
ces, but patients were better than controls on verbal com-
prehension and perceptual organization and worse on
working memory and processing speed. The processing
speed index, made up of digit symbol coding and symbol
search subtests, showed the biggest effect size for discrim-
inating patient and control performance, a finding which
applied even to a subgroup ofmatched pairs with IQ in the
high-average range. This finding is in agreement with a re-
cent meta-analysis,14 which showed that, out of a wide
range of neuropsychological measures, performance on
the digit-symbol test was by far the most sensitive index
differentiating schizophrenia patients from controls.
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Two compatible studies15,16 have shown that schizophre-
nia patients with normal intellectual function are impaired
on a psychophysiological measure of processing speed, in-
spection time. Others have found that performance on
tests of processing speed are significantly correlated
with neuropsychological indices of memory and executive
function in schizophrenia patients.17–21
Taken together these findings suggest that patients
with schizophrenia may be impaired on tests of memory
and executive function when matched to controls on IQ
because the tests share aspects of performance linked to
processing speed rather than because they represent sep-
arable cognitive functions. To test this hypothesis, we
adopted the approach of Wilk al13 and matched schizo-
phrenia patients with healthy volunteers, one-to-one on
current IQ; we additionally matched subjects for age and
sex. We used a 4 subtest version of the WAIS-III that in-
cluded digit symbol coding and has been validated for use
with schizophrenia.22 We also compared the groups on
estimated premorbid IQ and measures of memory and
executive function. We predicted that, although the
groups were precisely matched for IQ, differences in pro-
cessing speed would still be evident and that this would be
highly associated with impairments in memory and exec-
utive function in the patients. Patients were tested at the
time of presentation with their first psychotic episode and
1 year later to examine the trajectory of these cognitive
functions in the context of symptom change and longer
term medication effects.
Methods
Participants
The patients were recruited for this study as part of a lon-
gitudinal study of first-episode psychosis inWest London.
Patients were screened for eligibility for the study using the
World Health Organization (WHO) Psychosis Screen,23
and the inclusion criteria were as follows: aged between
16 and 50 years, presenting with a psychotic illness for
the first time, and had no more than 12 weeks cumulative
exposure to antipsychotic medication prior to baseline
assessment. In each case, the diagnosis was ascertained
using a structured interview, the diagnostic module of the
Diagnostic Interview for Psychosis,24 which includes
items from the Operational Criteria Checklist for Psycho-
sis25 (OPCRIT) and the WHO Schedules for Clinical
Assessment in Neuropsychiatry.26 Healthy volunteers
served as control subjects and were recruited from the
same catchment area as patients by advertising in local
colleges and hospitals. For the controls, participants
were excluded if they had a history of psychiatric illness
in themselves or their first-degree relatives. For both
groups, exclusion criteria were previous head injury or
other neurological illness or endocrine disorder affecting
brain function, such as epilepsy and thyroid disease, and
drug or alcohol dependence.
Fifty-three patients and 53 controls were selected for
this study on the basis that they had an initial diagnosis
of schizophrenia, schizophreniform, or schizoaffective
disorder; a currentWAIS IQof70; and could be individ-
ually matched with controls on sex, WAIS IQ within
3 points, and age within 10 years. Twenty-three patient-
control pairs had exactly the same IQ, 5 within one point,
21 within 2 points, and 4 within 3 points. Themean differ-
ence in age for thepairswas 3.45 years (see table 1).Aspart
of the prospective, longitudinal study, the patients and the
communitymental health teams are routinely contacted 1
year later at which time the diagnosis is reviewed. Thirty-
nine patients agreed to undergo a repeat diagnostic inter-
view. The diagnosis of the remaining 14 patients was
established by 2 psychiatrists (T.R.E.B. andE.M.J.) using
theOPCRIT to compile information from the responsible
Table 1. Comparison of Schizophrenia and Control Groups on Demographic Details, Executive Function, and Memory
Patients Controls Comparison
N 53 53
Sex 34 M/19 F 34 M/19 F
Age in years: mean (SD) 26.77 (7.75) 26.49 (6.70) F1,105 = 0.04, P = .841
Years of education: mean (SD) 12.79 (2.07) 13.74 (2.14) F1,105 = 5.32, P = .023
Cognitive measures: mean (SD)
Premorbid IQ (WTAR) 101.30 (9.27) 97.75 (8.91) F1,105 = 4.04, P = .047
Current IQ 98.67 (13.68) 98.32 (13.65) F1,105 = 0.02, P = .893
Spatial Span 5.84 (1.19) 6.37 (1.33) F1,103 = 4.39, P = .039
Spatial Working Memory (errors) 13.51 (9.80) 8.90 (8,84) F1,103 = 14.47, P < .001
a
Tower of London (perfect solutions) 7.49 (2.69) 8.42 (1.91) F1,101 = 3.13, P = .08
IDED (extradimensional shift errors) 13.51 (9.80) 8.90 (8.83) F1,101 = 6.22, P = .014
Verbal memory (summed recall over learning trials) 42.98 (8.32) 48.71 (10.25) F1,105 = 10.00, P = .002
a
Pattern Recognition Memory (number correctly recognized) 19.73 (3.05) 21.44 (2.45) F1,103 = 9.97, P = .002
a
Note: M, male; F, female; WTAR, Wechsler Test of Adult Reading; IDED, Intra/Extra Dimensional Set Shift.
aSignificant after Bonferroni correction (P < .005).
IQ, Memory, Executive Function, and Processing Speed
401
 at City U
niversity, London on February 16, 2015
http://schizophreniabulletin.oxfordjournals.org/
D
ow
nloaded from
 
psychiatrists, community psychiatric nurses, and the clin-
ical notes. The final Diagnostic and Statistical Manual of
Mental Disorders, Fourth Edition, diagnoses at follow-up
were schizophrenia in 41 patients and schizoaffective dis-
order in 12 patients.
Of the initial 53 patient-control pairs, the same neuro-
psychological assessments 1 year after baseline assessment
were available in 29 pairs. At the time of baseline testing, 3
patients were not being prescribed antipsychotic medica-
tion, 2 were being prescribed first-generation antipsy-
chotics, and 48 second-generation antipsychotics. Two
patients were also being prescribed anticholinergic medi-
cation. Of those who underwent neuropsychological reas-
sessment at 1-year follow-up (n = 29), those prescribed
second-generation antipsychotics at baseline continued
with the same medications, one had been switched from
first- to second-generation antipsychotics, and the
remaining patient who was drug naive was being pre-
scribed second-generation antipsychotics. None of this
subgroup was being prescribed anticholinergic medica-
tion at either time point. Permission to conduct the study
was obtained from Merton, Sutton and Wandsworth,
Riverside, and Ealing Research Ethics Committees. All
participants gave written informed consent and were
paid an honorarium for their time.
Clinical Assessments
Psychotic symptoms were assessed in all patients with the
Scales for the Assessment of Positive27 and Negative28
Symptoms. Scores for the 3 symptom-derived syndromes
of schizophrenia (positive, negative, disorganization)
were calculated for each patient.29 The Hamilton Rating
Scale for Depression30 and The Young Mania Scale31
were used to assess affective symptoms. To establish
the timing of onset of the psychotic illness, the Notting-
ham Onset Scale32 (NOS) was used. The NOS is a short,
guided interview and rating scale that records the details
of the components of onset of a psychotic illness. It
defines onset as comprising (a) a prodrome of 2 phases:
a period of ‘‘unease’’ followed by a period of ‘‘nondiag-
nostic’’ symptoms, (b) the emergence of psychotic symp-
toms, and (c) the buildup of diagnostic symptoms leading
to a definite diagnosis. The duration of untreated psycho-
sis (DUP) was taken as the period of time between stage
b and treatment onset. Age at onset was taken as the age
when stage b was reached.
Neuropsychological Assessment
Current IQ was measured using a short form of the
WAIS-III validated for use with schizophrenia.22 This
comprised 4 subtests from the WAIS-III,33 each repre-
senting 1 of the 4 indices: information (verbal compre-
hension index), arithmetic (working memory index),
block design (perceptual organization index), and digit
symbol (processing speed index). A prorated full-scale
IQ (FSIQ) was calculated using these 4 subtests, and
this method has been shown to provide a reliable mea-
sure of FSIQ in psychosis.22,34 Premorbid IQ was esti-
mated using the Wechsler Test of Adult Reading35
(WTAR).
Memory and executive function tests were taken
from the Cambridge Automated Neuropsychological
Test Battery.36 The measures employed were as follows.
Attentional set shifting: Taken from the Intra/Extradi-
mensional Set Shift task. The number of errors made dur-
ing the extradimensional shift stage was used. This stage
measures the ability to inhibit an attentional set toward
one dimension of a stimulus and switch attention to an-
other dimension of the same stimulus. Planning: Taken
from the stockings of Cambridge task. This is analogous
to the Tower of London task. In a series of problems
varying in difficulty, subjects plan and execute a se-
quence of moves of stimuli in a visual array to match
a goal array. The number of moves required range
from 2 to 5 with 12 trials in total. The total number
of perfect solutions was measured. Working memory
manipulation: Taken from the Spatial Working Mem-
ory task. This is a self-ordered search task whereby par-
ticipants need to recall where previous ‘‘tokens’’ were
found from a random array of ‘‘boxes’’ in order to max-
imize success at finding subsequent ‘‘tokens.’’ The num-
ber of search errors was measured. Working memory
span: Taken from the Spatial Span task. This test of for-
ward spatial span is akin to the Corsi block test. The
maximum number of consecutively presented spatial
locations that were successfully recalled was measured.
Visual recognition memory: Taken from the Pattern
Recognition Memory test. This task requires identifica-
tion of previously presented abstract patterns in a 2-
choice recognition paradigm. The number of patterns
correctly identified was measured.
Verbal learning and memory were measured with the
Rey Auditory Verbal Learning Task.37 The participant is
repeatedly read a list of 15 nouns and required to recall as
many as possible immediately after each trial and again
after presentation of a distractor list and finally after a 25-
to 30-minute delay. The sum of words recalled over the 5
learning trials was used as a measure of episodic verbal
recall memory.
Analysis
Data were analyzed using SPSS version 15. Group differ-
ences were examined with analysis of variance (ANOVA)
or covariance (ANCOVA) and paired t test where appro-
priate. Pearson r correlations were used to examine asso-
ciations between measures. Stepped linear regression was
used to determine whether any cognitive measures pre-
dicted clinical outcome. Wilcoxon signed ranks test
was used for repeated-measures analyses of categorical
scores.
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In additional to scaled scores, WAIS-III subtest–
standardized residual scores38 were calculated for the
patients. A standardized residual score reflects the de-
gree to which performance on each particular WAIS
subtest deviates from that predicted by the FSIQ score
in each individual, based on the relationship between
FSIQ and the relevant subtest in the control group.
The score is calculated for each subtest by regressing
the relevant scaled score on FSIQ using the control
group data then calculating a residual score for each pa-
tient based on this equation. Finally, the residual score
was divided by the SE of the regression in the control
group giving a standardized residual score for each
patient on each subtest.
Results
A mixed within- and between-subjects ANOVA with the
4 WAIS subtest–scaled scores entered as the within-
subjects factor and group as the between-subjects factor
revealed amain effect of subtest (F3,312 = 38.99, P< .001,
g´
2
p=0.27) indicating that the performance profile for both
groups was not flat (see figure 1). To explore this further,
post hoc within-subjects contrasts were performed across
all subjects. The mean of each subtest was compared
with the grand mean of all other subtests, showing
that the significant main effect reflected individual sub-
test-scaled scores that were lower than average for arith-
metic (F = 6.78, P = .005) and digit symbol (F = 67.15,
P < .001) and higher than average for information
(F = 94.58,P< .001) and block design (F = 8.38,P = .005).
There was also a significant interaction between sub-
test and group (F3,312 = 4.10,P = .007, g´
2
p=0.04). Univar-
iate ANOVAs revealed that the groups were not
significantly different on information (F1,105 = 0.44,
P = .510), arithmetic (F1,105 = 1.09, P = .300), and block
design (F1,105 = 0.74, P = .393) but that the patients had
significantly lower digit symbol–scaled scores than the
controls (F1,105 = 7.16,P = .009) as illustrated in figure 1.
Figure 1 also shows the standardized residual scores of
each patient for each subtest illustrating the degree to
which performance on each subtest differed from that
predicted. A repeated-measures ANOVA on the stan-
dardized residual scores showed a significant effect of
subtest (F3,156 = 7.30, P < .001, g´
2
p=0.12). Post hoc
within-subjects contrasts comparing digit symbol resid-
ual scores to each of the other 3 scores confirmed that
patient performance was significantly worse than pre-
dicted on digit symbol as compared with information
(F = 13.22, P = .001), arithmetic (F = 17.43, P < .001),
and block design (F = 12.25, P = .001), all of which sur-
vived Bonferroni correction (P < .016).
Univariate ANOVAs revealed that the patients had
significantly poorer performance than controls on the
measures of memory and executive function with verbal
recall memory, working memory manipulation and
visual recognition memory remaining significant after
Bonferroni correction (see table 1).
Pearson r correlations showed IQ to be significantly
correlated with all memory and executive scores in
both groups (see table 2). Digit symbol performance cor-
related highly with working memory manipulation in
both groups and with verbal learning in the patient
group. Because digit symbol score differentiated patients
from controls in addition to these 2 variables, we per-
formed ANCOVAs to determine the degree to which
group differences in working memory manipulation
and verbal learning was associated with differences in
digit symbol performance. For working memory manip-
ulation, digit symbol was a highly significant covariate
(F1,100 = 16.01, P < .001), but the difference between
the 2 groups remained significant (F1,100 = 8.62, P =
.004). For verbal learning, digit symbol was also a highly
significant covariate (F1,106 = 31.74, P < .001), but again
the difference between the 2 groups remained significant
(F1,106 = 4.21, P = .043).
To test the specificity of the relationship between digit
symbol performance and other cognitive variables, we
analyzed a patient subgroup that obtained a scaled score
of <9 on the digit symbol subtest and were therefore in
the lowest quartile of the general population according to
the WAIS-III scoring manual (n = 38). As in the group as
a whole, Pearson r correlations showed no significant
correlation between the digit symbol score and visual
Fig. 1. Scaled Scores and Standardized Residual Scores for Each
Wechsler Adult Intelligence Scale III Subtests. Mean patient and
control data are shown for scaled scores, and individual patient data
are shown for the residual scores.
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recognitionmemory (r = 0.08), workingmemory span (r =
0.15), planning (r = 0.05), or set shifting (r = 0.10).
Change Over Time
Twenty-nine pairs of participants underwent retesting af-
ter approximately 12months.With regard to the patients,
those that were tested as a follow-up pair did not differ
significantly from those that were not on IQ, age at first
assessment, psychotic syndrome scores, scores for depres-
sion and mania, DUP, and age at onset (range of Fs =
0.01–1.60, all P > .1).
Wilcoxon signed ranks showed that those retested expe-
rienced significant improvement in symptoms. Nineteen
showed reduced negative syndrome (z = 2.10,
P = .036), 22 had reduced positive syndrome (z = 3.65,
P < .001), and 20 had reduced disorganization syndrome
(z = 3.79, P < .001).
Table 3 shows the mean first-episode and follow-up
WAIS-III IQ and subtest-scaled scores for patients and
controls. For IQ, a repeated-measures ANOVA was per-
formed with time as the within-subjects factor (baseline,
1 year) and group as the between-subjects factor. The
main effect of time was not significant (F1,56 = 1.46,
P = .233, g´2p = 0.03), but there was a significant interaction
between time and group (F1,56 = 7.79, P = .007, g´
2
p = 0.12).
The individual scaled scores were therefore examined.
There were no significant main effects or interactions
for information (time: F1,56 = 2.73, P = .104, g´
2
p = 0.05;
time 3 group: F1,56 = 1.28,P = .263, g´
2
p = 0.02), arithmetic
(time: F1,56 = 0.34, P = .565, g´
2
p = 0.01; time 3 group:
F1,56 = 162, P = .208, g´
2
p = 0.03), or block design (time:
F1,56 = 0.01, P = .959, g´
2
p = 0.00; time 3 group: F1,56 =
1.17, P = .285, g´2p = 0.02). For digit symbol, there was
no effect of time (F1,56 = 0.64, P = .426, g´
2
p = 0.01),
but there was a significant interaction between time
and group (F1,56 = 8.35, P = .005, g´
2
p = 0.13). Paired t tests
showed that this reflected a nonsignificant decline in the
patients (t28 = 1.44, P = .162) and a significant improve-
ment in the controls (t28 = 3.02, P = .005).
Table 2. Correlations Between IQ and WAIS Subtest–Scaled Scores and Other Neuropsychological Measures in Patients and Controls
Controls Patients
FSIQ Information Arithmetic
Block
Design
Digit
Symbol FSIQ Information Arithmetic
Block
Design
Digit
Symbol
Spatial Span 0.28* 0.13 0.32* 0.09 0.23 0.44** 0.30* 0.27 0.33* 0.30*
Spatial Working
Memory (errors)
0.46** 0.26 0.44*** 0.38** 0.26 0.53*** 0.37** 0.42** 0.25 0.50***
IDED
(extradimensional
shift errors)
0.45*** 0.30* 0.38** 0.48*** 0.13 0.40** 0.29* 0.31* 0.38** 0.12
Verbal learning
(summed recall
over learning
trials)
0.47*** 0.38** 0.32* 0.25 0.43** 0.31* 0.13 0.05 0.20 0.55***
Pattern Recognition
Memory (number
correctly recalled)
0.28* 0.27 0.12 0.17 0.27 0.37** 0.29* 0.38** 0.17 0.21
Note: WAIS, Wechsler Adult Intelligence Scale; FSIQ, full-scale IQ. Emboldened figures are significant after Bonferroni correction
(P < .002).
*Significant at P < .05; **significant at P < .01; ***significant at P < .001.
Table 3. First-Episode and 1-Year Follow-up IQ and Scaled Scores of the Patients and Controls on Each WAIS Subtest
WAIS Subtest: Mean (SD)
Patients, n = 29 Controls, n = 29
Initial Follow-up Initial Follow-up
FSIQ 98.62 (11.75) 97.10 (9.73) 98.24 (11.82) 102.07 (11.43)
Information 11.45 (2.28) 11.55 (2.28) 11.21 (2.06) 11.76 (2.40)
Arithmetic 9.69 (2.84) 9.48 (2.59) 9.03 (2.92) 9.59 (2.81)
Block design 10.24 (2.98) 9.90 (1.99) 10.38 (3.14) 10.76 (2.82)
Digit symbol 7.98 (2.74) 7.51 (2.43) 8.52 (2.16) 9.31 (2.17)
Note: WAIS, Wechsler Adult Intelligence Scale; FSIQ, full-scale IQ.
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Relationship With Clinical Variables
Pearson r correlations revealed that the negative syn-
drome score was significantly and inversely correlated
with FSIQ, digit symbol–scaled score, and digit sym-
bol–standardized residual score at initial assessment
(see table 4). The disorganization syndrome score was sig-
nificantly inversely correlated with block design–scaled
score. The Young Mania Scale score was also inversely
correlatedwithblockdesigndeviation scoreandpositively
correlatedwith arithmetic deviation score. However, only
the correlation between the negative syndrome score and
digit symbol–scaled score withstood Bonferroni correc-
tion for multiple comparisons (P = .0008). Pearson r cor-
relations revealed that digit symbol scorewas significantly
correlated with all the global subscale scores comprising
the negative syndrome: affective flattening (r = 0.57),
alogia (r = 0.48), and anhedonia/asociality (r = 0.44)
were all correlated at P < .001; avolition/apathy (r =
0.41) at P < .01; and attention (r = 0.30) at P < .05.
Predictors of 1-Year Clinical Outcome From Baseline
WAIS-III Subscale Scores
We used the significant (P < .05) correlations between
baseline clinical and WAIS-III scores to determine the
analysis of 1-year clinical outcome in those pairs that
had been successfully followed up. In each case, a linear
regression was used to determine whether the relevant
baseline cognitive score was a significant predictor of
the 1-year clinical measure, once the equivalent baseline
clinical measure was already entered as a predictor in the
model. Thus, controlling for baseline symptoms, we
found no effects of block design on disorganization (first
step: baseline syndrome score r2 = 0.02, F1,27 = 0.37, P =
.550; second step: baseline block design–scaled score r2 =
0.02, F1,26 = 0.70,P = .409), arithmetic on disorganization
(first step: baseline syndrome score r2 = 0.01, F1,27 = 0.37,
P = .550; second step: baseline block design–scaled score
r2 = 0.05, F1,26 = 1.17,P = .290), arithmetic onmania (first
step: baseline mania score r2 = 0.01, F1,27 = 0.28, P = .602;
second step: baseline arithmetic-standardized residual
score r2 = 0.03, F1,26 = 0.70, P = .409), or block design
on mania (first step: baseline mania score r2 = 0.01,
F1,27 = 0.28, P = .602; second step: baseline block de-
sign–standardized residual score r2 = 0.04, F1,26 =
1.106, P = .312). Regarding the negative syndrome, digit
symbol–scaled score had no effect (first step: baseline
syndrome score r2 = 0.11, F1,27 = 3.45, P = .074; second
step: baseline digit symbol–scaled score r2 = 0.01, F1,26 =
0.35, P = .559), but digit symbol–standardized residual
score accounted for a significant amount of the variance
in the negative syndrome score once the baseline negative
syndrome had been taken into account (second step:
baseline digit symbol–standardized residual score r2 =
0.16, F1,26 = 5.83, P = .023).
Discussion
In this study, we compared patients with recent-onset
schizophrenia and healthy controls, individually matched
for sex, age, and WAIS-III IQ on scaled scores of the 4
subtests that contributed to their IQ score.22 The main
aim of the study was to ascertain whether performance
on a test of processing speed, digit symbol coding, is dis-
proportionally impaired in patients with recent-onset
schizophrenia who otherwise have intact intellectual
function. A second aim was to examine the relationship
between processing speed and memory and executive
function as well as symptoms at first episode and over
time. We found that the patients were significantly im-
paired on digit symbol coding but were no different
fromcontrols on information, arithmetic, or blockdesign.
Standardized residual scores of the patients, basedon con-
trol performance, indicated that only performance on the
Table 4. Pearson r Correlations Between IQ, Scaled Scores, and Standardized Residual Scores for Each of the 4 WAIS-III Subtests and
Clinical Measures at First Presentation
FSIQ
Scaled Scores Standardized Residual Scores
Information Arithmetic
Block
Design
Digit
Symbol Information Arithmetic
Block
Design
Digit
Symbol
DUP (wk) 0.03 0.02 0.05 0.02 0.19 0.01 0.12 0.06 0.19
Age at onset of psychosis 0.02 0.11 0.11 0.15 0.24 0.18 0.14 0.22 0.26
Negative syndrome 0.32* 0.11 0.09 0.18 0.56 0.18 0.24 0.02 0.41**
Positive syndrome 0.05 0.11 0.12 0.06 0.05 0.12 0.11 0.13 0.02
Disorganization syndrome 0.23 0.15 0.00 0.29* 0.18 0.02 0.28* 0.22 0.04
Hamilton Depression Scale 0.01 0.02 0.03 0.03 0.04 0.02 0.03 0.05 0.04
Young Mania Scale 0.06 0.01 0.26 0.20 0.16 0.08 0.32* 0.34* 0.14
Note: WAIS-III, Wechsler Adult Intelligence Scale III; FSIQ, full-scale IQ; DUP, duration of untreated psychosis.
*Significant at P < .05; **significant at P < .01; ***significant at P < .001.
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digit symbol subtest deviated significantly from that
expected given their IQ. When we retested a subgroup
of patient-control pairs 1 year later, the controls showed
significant improvement in digit symbol performance but
the patients showed no change despite significant amelio-
ration of symptoms with treatment, a finding compatible
with a previous longitudinal study of first-episode schizo-
phrenia.39Our findings are also consistent with the results
of a recent meta-analysis14 showing that, out of a large
range of neuropsychological tests, digit symbol coding
was by far the most sensitive marker of cognitive impair-
ment in schizophrenia.14 The authors also showed that
digit symbol impairment was the most sensitive indicator
of cognitive impairment in nonpsychotic relatives of
patients with schizophrenia and point out that perfor-
mance on this taskhas been shown todifferentiate siblings
at high risk of schizophrenia who later became psychotic
from those who do not.40 Taken together, these findings
indicate that impaireddigit symbolperformance is a stable
trait in schizophrenia and reflects an abnormal cognitive
process central to the disorder: it is present at the onset of
psychosis in the context of intact performance on other
tests of general intellectual ability; it is impervious to prac-
tice effects and is unaffected by antipsychotic medication
over the first year of the illness.
Digit symbol performance was also sensitive to symp-
tom severity in our study. We correlated IQ and individ-
ual subtest scores with psychotic and affective symptoms,
age of onset, and DUP. For each subtest, we considered
the scaled score and the standardized residual score. The
results showed several modestly significant relationships
between clinical and cognitive measures, but, following
correction for multiple comparisons, only an inverse
relationship between the negative syndrome and digit
symbol–scaled score remained significant. When we ex-
amined the predictive value of digit symbol performance
in a subset of patients for whom we also had follow-up
data, the digit symbol–standardized residual score was
found to predict a significant amount of the remaining
variance in the 1-year negative syndrome score after hav-
ing accounted for the contribution of negative symptoms
at presentation. Thus, the magnitude of relative impair-
ment in digit symbol performance at the first psychotic ep-
isode was a prognostic factor for poor early outcome with
respect to the development or persistence of negative
symptoms. The contribution of the first-episode digit
symbol–standardized residual score to the negative syn-
drome at follow-up was 20% after baseline negative syn-
drome score was already entered into the model. This
suggests that the finding is not simply an artifact of mea-
surement whereby the scales for negative syndrome and
digit symbol subtest are measuring a shared characteristic.
This distinction is important because digit symbol is
a timed task and the negative syndrome incorporates con-
cepts such as avolition, affective flattening, and attention
that could adversely impact on reaction times.
In this study, we also found that, despite precisely
matching for IQ, patients were impaired on measures
of memory and executive function, replicating our find-
ings in a different, larger group of first-episode patients5,7
and in keeping with studies of patients with more long-
standing illness.8–11,15 The differences were particularly
large for verbal learning, visual recognition memory,
and a measure of spatial working memory manipulation.
Verbal learning and spatial working memory correlated
strongly with digit symbol performance in the patients
and to a lesser extent in controls. Because neither the ver-
bal learning nor working memory tests had a timed com-
ponent, the association with digit symbol was not
secondary to a common procedural factor. One explana-
tion is that the cognitive processes measured by the verbal
memory and spatial working memory tests were ham-
pered in the patients by poor information processing
speed.41 An alternative explanation however is that the
association was due to both sets of measures being sen-
sitive to a generalized impairment. Other first-episode
studies have found that a significant proportion of the
performance variance across a number of neuropsycho-
logical tests is accounted for by a single general factor in
data reduction models.42,43 One of these studies included
the digit symbol test and found that the weight of loading
of this test score onto the general factor was similar in
magnitude to that of a number of other neuropsycholog-
ical tests.42 Although digit symbol was the only IQ sub-
test to discriminate patients and controls in our study, it
is noteworthy that IQ, as a composite measure of general
intellectual ability, was in both groups a better correlate
of performance on the tests of memory and executive
function than the IQ subtests taken individually. Thus,
performance on the digit symbol test in our study may
have contributed to a general ability factor underpinning
performance on the verbal learning and spatial working
memory tests rather than it being uniquely relevant for
these cognitive functions. In addition, although further
analysis showed a highly significant digit symbol covari-
ate effect, significant differences between the groups
remained on verbal learning and spatial workingmemory
tests suggesting that, even if processing speed contributed
to performance, other cognitive processes were also im-
portant in discriminating patients from controls. Finally,
the correlations between digit symbol performance and
measures of set shifting and visual recognition memory
were small and not statistically significant, even when
we examined this in a subgroup of patients with ex-
tremely poor digit symbol performance. This suggests
that not all aspects of neuropsychological performance
in schizophrenia can be attributed to slow information
processing speed, at least as measured by this test.
In keeping with the argument that digit symbol perfor-
mance is a relatively nonspecific indicator of cognitive
dysfunction, deficits on this test have been demonstrated
in a number of different cognitive disorders suggesting
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that it may be multifactorial in nature.37 Thus, the find-
ings in schizophreniamay be explained by the psychomet-
ric properties of the test rather than it identifying
a fundamental cognitive process that is impaired above
all others. Joy et al44,45 suggest,with experimental support,
that digit symbol performance in young healthy subjects is
comprised of independent contributions from motor
speed, cognitive speed, and visual scanning efficiency pri-
marily and, to a lesser extent, from visual memory (for
digit-symbol pairs) and set-shifting ability (between digits
and symbols). Two further studies,46,47 also in young
healthy subjects, analyzed eye movements during digit
symbol performance and found that time spent inspecting
the code correlated highly with performance whereas time
spentwritingdidnot.Thissuggests thatthespeedofsearch-
ing and encoding information was a more important pro-
cess than simple motor speed for performance. Taken
together, these studies indicate that digit symbol is primar-
ily a test of speed, particularly cognitive speed, in young
healthy adults. There are indications that this is also the
case in schizophrenia,48 but further studies are required
to decompose the processes contributing to digit symbol
performance in this disorder.14
There is also accumulating and convergent evidence
from other studies that tests of processing speed are
indexing something fundamental about schizophrenia.
For example, several studies in addition to ours have
reported specific relationships between the negative syn-
drome and processing speed.49–52 Of particular note is
a study50 that used relatively unconfounded measures
of processing speed in different sensory modalities in
a large sample of patients and found that the negative
syndrome, but not disorganization or positive syn-
dromes, accounted for a significant amount of the vari-
ance in auditory reaction time and visual backward
masking measures. Other studies, like ours, have found
significant statistical associations between performance
on tests of processing speed and other neuropsycholog-
ical functions in schizophrenia,17–21 and Badcock16 has
shown that the psychophysiological measure, inspection
time, inversely correlated with performance IQ. How-
ever, because these are association studies, it is difficult
to conclude that measures of processing speed reflect
a process that mediates individual differences in perfor-
mance of the more complex psychometric tasks. Exper-
imental work has addressed this point more specifically.
For example, by manipulating target exposure time or
posttarget processing time, studies have shown that im-
paired working memory performance reflects, to a signif-
icant extent, slowing of information processing
speed.53,54 We have previously shown, by analyzing
eye movements during performance of a complex plan-
ning task, that patients were not generally slow and
approached and executed the task in the same strategic
manner as controls; the only difference between the
groups explaining poorer performance in the patients
was that they spent longer fixating targets suggesting
that they had difficulty in encoding features essential
for performance.55
Several other aspects of our study deserve comment.
The first concerns the representativeness of the sample.
The IQ of both the patients and controls group ranged
from ‘‘borderline low’’ to ‘‘superior.’’ However, because
IQ is normally lower in schizophrenia than in healthy sub-
jects, our patient group was inevitably biased toward the
higher end of the IQ spectrum for this disorder in order to
obtain one-to-one IQ matching with controls. Our find-
ings therefore may not be typical for schizophrenia. Nev-
ertheless, this method allowed us to detect certain
cognitive impairments even in patients who would be con-
sidered normal on the basis of their intellectual ability.56,57
The elucidation of cognitive impairment in the context of
groups matched for normal IQ has also been a positive
strategy in previous studies of schizophrenia.10,11
A second point concerns why patients scored the same
IQ as controls despite being worse on digit symbol that
contributed to the IQ calculation. In accordance with the
study of Wilk et al,13 we had expected that any subtest
impairment in patients would be ‘‘balanced’’ by better
performance in others. There was some support for
this in that patients were numerically better than controls
on the other 3 subtests, but none of the differences were
significant. A further indication that the patients were
better than controls on some aspects of cognition comes
from the finding that premorbid IQ was significantly
higher in the patients. Premorbid IQ was estimated using
a reading test, the WTAR, which assesses knowledge of
irregular word pronunciation and is therefore a measure
of vocabulary. Vocabulary in turn is a measure of crys-
talline intelligence that is more impervious to brain
changes than fluid intelligence, reflected in problem solv-
ing ability and processing speed.58Although the differen-
ces between premorbid and current IQ estimates were
small, they suggest that the patients had undergone intel-
lectual decline as a consequence of the illness and are thus
in keeping with the findings of other studies.5–11,13,15
In summary, our findings add to a growing body of
work demonstrating the importance of processing speed
for cognitive function and clinical outcome in schizophre-
nia. We found that an index of processing speed, digit
symbol coding, was disproportionately impaired early
in the course of the illness and that this was highly asso-
ciated with working memory and verbal learning impair-
ment; cognitive domains frequently reported to be
abnormal in schizophrenia. This processing speed mea-
sure was also uniquely related to symptoms, in that it
was inversely correlated with the severity of current neg-
ative symptoms and the relative level of underperform-
ance in processing speed predicted the severity of
negative symptoms 1 year later. Further work is required
to ascertain whether processing speed is specific and
fundamental to higher order cognitive processes in
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schizophrenia or whether it is one component of a more
generalized deficit.
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